Vivos Therapeutics Exercises Warrants for $4.64mln at Reduced Price.

Vivos Therapeutics has entered into a definitive agreement to exercise outstanding warrants for up to 1,982,356 shares of common stock at a reduced exercise price of $2.34 per share. The gross proceeds from the exercise are expected to be approximately $4.64 million. The shares are registered for resale under an effective registration statement on Form S-3.